Jaya Punetha1, Soledad Monges2, Maria Emilia Franchi2, Eric P Hoffman1, Sebahattin Cirak3, Carolina Tesi-Rocha4. 1. Department of Integrative Systems Biology, The George Washington University School of Medicine, Washington, DC; Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC. 2. Hospital Nacional de Pediatria "J. P. Garrahan", Buenos Aires, Argentina. 3. Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC. 4. Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC; Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, California. Electronic address: ctesiroc@hotmail.com.
Abstract
BACKGROUND: Molecular diagnosis of the distal spinal muscular atrophies or distal hereditary motor neuropathies remains challenging because of clinical and genetic heterogeneity. Next generation sequencing offers potential for identifying de novo mutations of causative genes in isolated cases. PATIENT DESCRIPTION: We present a 3.6-year-old girl with congenital scoliosis, equinovarus, and L5/S1 left hemivertebra who demonstrated delayed walking and lower extremities atrophy. She was negative for SMN1 deletion testing, and parents show no sign of disease. RESULTS: Whole exome sequencing of the affected girl showed a novel de novo heterozygous missense mutation c.1792C>T (p.Arg598Cys) in the tail domain of the DYNC1H1 gene encoding for cytoplasmic dynein heavy chain 1. The mutation changed a highly conserved amino acid and was absent from both parents. CONCLUSION: De novo mutations of DYNC1H1 have been found in individuals with autosomal dominant mental retardation with neuronal migration defects. Dominantly inherited mutations of DYNC1H1 have been reported to cause spinal muscular atrophy with predominance of lower extremity involvement and Charcot-Marie-Tooth type 2O. This is the first report of a de novoDYNC1H1 mutation associated with the spinal muscular atrophy with predominance of lower extremity phenotype with a spinal deformity (lumbar hemivertebrae). This case also demonstrates the power of next generation sequencing to discover de novo mutations on a genome-wide scale.
BACKGROUND: Molecular diagnosis of the distal spinal muscular atrophies or distal hereditary motor neuropathies remains challenging because of clinical and genetic heterogeneity. Next generation sequencing offers potential for identifying de novo mutations of causative genes in isolated cases. PATIENT DESCRIPTION: We present a 3.6-year-old girl with congenital scoliosis, equinovarus, and L5/S1 left hemivertebra who demonstrated delayed walking and lower extremities atrophy. She was negative for SMN1 deletion testing, and parents show no sign of disease. RESULTS: Whole exome sequencing of the affected girl showed a novel de novo heterozygous missense mutation c.1792C>T (p.Arg598Cys) in the tail domain of the DYNC1H1 gene encoding for cytoplasmic dynein heavy chain 1. The mutation changed a highly conserved amino acid and was absent from both parents. CONCLUSION: De novo mutations of DYNC1H1 have been found in individuals with autosomal dominant mental retardation with neuronal migration defects. Dominantly inherited mutations of DYNC1H1 have been reported to cause spinal muscular atrophy with predominance of lower extremity involvement and Charcot-Marie-Tooth type 2O. This is the first report of a de novoDYNC1H1 mutation associated with the spinal muscular atrophy with predominance of lower extremity phenotype with a spinal deformity (lumbar hemivertebrae). This case also demonstrates the power of next generation sequencing to discover de novo mutations on a genome-wide scale.
Authors: Hristelina S Ilieva; Koji Yamanaka; Shelle Malkmus; Osamu Kakinohana; Tony Yaksh; Martin Marsala; Don W Cleveland Journal: Proc Natl Acad Sci U S A Date: 2008-08-21 Impact factor: 11.205
Authors: Joy Irobi; Ines Dierick; Albena Jordanova; Kristl G Claeys; Peter De Jonghe; Vincent Timmerman Journal: Neuromolecular Med Date: 2006 Impact factor: 3.843
Authors: M B Harms; K M Ori-McKenney; M Scoto; E P Tuck; S Bell; D Ma; S Masi; P Allred; M Al-Lozi; M M Reilly; L J Miller; A Jani-Acsadi; A Pestronk; M E Shy; F Muntoni; R B Vallee; R H Baloh Journal: Neurology Date: 2012-03-28 Impact factor: 9.910
Authors: Majid Hafezparast; Rainer Klocke; Christiana Ruhrberg; Andreas Marquardt; Azlina Ahmad-Annuar; Samantha Bowen; Giovanna Lalli; Abi S Witherden; Holger Hummerich; Sharon Nicholson; P Jeffrey Morgan; Ravi Oozageer; John V Priestley; Sharon Averill; Von R King; Simon Ball; Jo Peters; Takashi Toda; Ayumu Yamamoto; Yasushi Hiraoka; Martin Augustin; Dirk Korthaus; Sigrid Wattler; Philipp Wabnitz; Carmen Dickneite; Stefan Lampel; Florian Boehme; Gisela Peraus; Andreas Popp; Martina Rudelius; Juergen Schlegel; Helmut Fuchs; Martin Hrabe de Angelis; Giampietro Schiavo; David T Shima; Andreas P Russ; Gabriele Stumm; Joanne E Martin; Elizabeth M C Fisher Journal: Science Date: 2003-05-02 Impact factor: 47.728
Authors: Lena Willkomm; Raul Heredia; Katrin Hoffmann; Haicui Wang; Thomas Voit; Eric P Hoffman; Sebahattin Cirak Journal: J Hum Genet Date: 2016-02-18 Impact factor: 3.172
Authors: Luke W Thompson; Kim D Morrison; Sally L Shirran; Ewout J N Groen; Thomas H Gillingwater; Catherine H Botting; Judith E Sleeman Journal: J Cell Sci Date: 2018-04-17 Impact factor: 5.285
Authors: Petra Laššuthová; Dana Šafka Brožková; Marcela Krůtová; Jana Neupauerová; Jana Haberlová; Radim Mazanec; Pavel Dřímal; Pavel Seeman Journal: Orphanet J Rare Dis Date: 2016-08-22 Impact factor: 4.123
Authors: Amy L Herbert; Meng-Meng Fu; Catherine M Drerup; Ryan S Gray; Breanne L Harty; Sarah D Ackerman; Thomas O'Reilly-Pol; Stephen L Johnson; Alex V Nechiporuk; Ben A Barres; Kelly R Monk Journal: Proc Natl Acad Sci U S A Date: 2017-10-12 Impact factor: 11.205